HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.

AbstractBACKGROUND:
Data on the burden of genital warts in terms of treatment costs and detriment to quality of life (QoL) are required to assess cost-effectiveness of quadrivalent human papillomavirus vaccination. We investigated the cost of treatment and period of time for which QoL is affected to obtain estimates of quality-adjusted life year (QALY) loss associated with an episode of genital warts.
METHODS:
Adults diagnosed with genital warts attending the York sexually transmitted disease clinic during two 3-month periods in 2006 and 2007 were enrolled (n = 189). Data on cost of treatment and duration of episode of care were collected from a retrospective case note review. QALY loss was calculated by applying estimates of the duration of time for which QoL was affected to the previously reported detriment to QoL associated with genital warts.
RESULTS:
The average cost per episode of care was 286 US dollars (139 pound, 95% CI: 246-327 US dollars). Estimated loss of QALYs ranged from 0.0045 (95% CI: 0.0014-0.0078) to 0.023 (95% CI: 0.0072-0.039).
CONCLUSIONS:
Genital warts present a significant burden both to individuals and to the health service. Data on the burden of genital warts should be incorporated into economic evaluations of human papillomavirus vaccination strategies.
AuthorsSarah C Woodhall, Mark Jit, Chun Cai, Tina Ramsey, Sadique Zia, Simon Crouch, Yvonne Birks, Robert Newton, W John Edmunds, Charles J N Lacey
JournalSexually transmitted diseases (Sex Transm Dis) Vol. 36 Issue 8 Pg. 515-21 (Aug 2009) ISSN: 1537-4521 [Electronic] United States
PMID19543143 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Papillomavirus Vaccines
Topics
  • Adolescent
  • Adult
  • Condylomata Acuminata (economics, epidemiology, prevention & control)
  • Costs and Cost Analysis
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Papillomavirus Infections (economics, epidemiology, prevention & control)
  • Papillomavirus Vaccines (administration & dosage, economics)
  • Quality of Life
  • Quality-Adjusted Life Years
  • Time Factors
  • United Kingdom (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: